ArticleBlood cancer discovery2020
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.
Article in Blood cancer discovery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.Hematological oncology · 2023Pooled it
- The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7).Addiction (Abingdon, England) · 2021Pooled it
- Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies.European journal of cancer (Oxford, England : 1990) · 2020Pooled it
- Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation.The Journal of clinical investigation · 2020Trial
- Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma.British journal of haematology · 2023Article
- COVID-19 Vaccine Responses in Patients With Plasma Cell Dyscrasias After Complete Vaccination.Clinical lymphoma, myeloma & leukemia · 2022Article
- COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view.Journal of molecular medicine (Berlin, Germany) · 2022Article
- Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma.Blood · 2022Article
- Impacts of COVID-19 on caregivers of childhood cancer survivors.Pediatric blood & cancer · 2021Article
- Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.Frontiers in oncology · 2021Review
- Outcome of COVID-19 in multiple myeloma patients in relation to treatment.European journal of haematology · 2020Article
- Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany.Haematologica · 2020Article
- Potential 'significance' of monoclonal gammopathy of 'undetermined significance' during COVID-19 pandemic.Blood cells, molecules & diseases · 2020Article
- The clinical impact of COVID-19 epidemic in the hematologic setting.Advances in biological regulation · 2020Review
Corrections and comments
- Erratum for
Authors and funding
30 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
[This corrects the article DOI: 10.1158/2643-3230.BCD-20-0102.].
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.